Form D filings with the SEC list Mark N. Lampert as an executive officer of BIOTECHNOLOGY VALUE FUND II. See sector focus.
Form D filings with the SEC list Mark N. Lampert as an executive officer of BIOTECHNOLOGY VALUE FUND II. The associated organization is BIOTECHNOLOGY VALUE FUND II. One Form D filing is on record, for the offering BIOTECHNOLOGY VALUE FUND II LP. The SEC industry group for this offering is Pooled Investment Fund. The minimum investment accepted for this offering is $25,000,000. The issuer address on file is San Francisco.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in San Francisco.
Investors like Mark N. Lampert · Full investor directory · Investor access · Company funding database